|
|
Other links at Articles > Business of Medicine |
| 1. |
New Cystic Fibrosis Drug Meets Trial Goal
|
|
|
A late-stage trial of denufosol, an inhaled cystic fibrosis drug, met the main study goal of significantly improving breathing, Inspire Pharmaceuticals Inc said Friday. Reuters Health Information
|
| 2. |
Two Lots of Noven, Shire ADHD Patch Recalled
|
|
|
Noven Pharmaceuticals Inc said on Monday that its marketing partner, Shire Ltd, is voluntarily recalling two batches of its skin patch to treat attention-deficit/hyperactivity disorder, because of difficulties removing the release liner when the patch is peeled open. Reuters Health Information
|
| 4. |
Celgene Wins US Approval to Expand Vidaza Label
|
|
|
Celgene Corp said on Thursday that U.S. regulators have given it the green light to add information to the label of its drug Vidaza showing it prolonged life in some patients with myelodysplastic syndromes, or MDS, a group of blood disorders that can lead to leukemia. Reuters Health Information
|
| 5. |
Britain Has "Four Different NHS Systems"
|
|
|
Devolution has inspired four different National Health Service systems each with their own priorities, a health boss said on Wednesday. Reuters Health Information
|
|
|
